Literature DB >> 3001326

Update in cancer chemotherapy, Part IV. Lung cancer, Part 2.

J C Wright.   

Abstract

An update of cancer chemotherapy in 1985 that deals with the various therapies of lung cancer is described. At present, the stage of the disease and cell type are the major factors that determine the treatment. Important differences in the biological behavior and response to treatment exist between small cell and non-small cell cancers. Treatment of the small cell type, which is sensitive to many of the cancer chemotherapeutic agents, is discussed in this paper. Treatment of the non-small cell types was described in the October issue of the Journal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001326      PMCID: PMC2571219     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  45 in total

1.  The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative study.

Authors:  G A Higgins; T W Shields; R J Keehn
Journal:  Arch Surg       Date:  1975-05

2.  Intrapleural tetracycline for malignant pleural effusions.

Authors:  H W Wallach
Journal:  Chest       Date:  1975-10       Impact factor: 9.410

3.  Treatment of malignant pleural effusion: a method using tube thoracostomy and talc.

Authors:  R H Adler; I Sayek
Journal:  Ann Thorac Surg       Date:  1976-07       Impact factor: 4.330

4.  Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.

Authors:  H H Hansen; F M Muggia; R Andrews; O S Selawry
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

5.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.

Authors:  W Fox; J G Scadding
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

6.  A clinical trial of intravenous and intracavitary bleomycin.

Authors:  T J Cunningham; K B Olson; J Horton; A Wright; M Hussain; J N Davies; G Harrington
Journal:  Cancer       Date:  1972-05       Impact factor: 6.860

7.  Alkylating agents in bronchogenic carcinoma.

Authors:  R A Green; E Humphrey; H Close; M E Patno
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

8.  Heparin and chemotherapy in the management of inoperable lung carcinoma.

Authors:  E G Elias; S K Shukla; I B Mink
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

9.  Indications for pleurectomy in malignant effusion.

Authors:  N Martini; M S Bains; E J Beattie
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

10.  Pleural effusion in cancer patients. A prospective randomized study of pleural drainage with the addition of radioactive phsophorous to the pleural space vs. pleural drainage alone.

Authors:  R Izbicki; B T Weyhing; L Baker; E M Caoili; V K Vaitkevicius
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.